Skip to Content

RushNet Inc RSHN

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RSHN is trading at a 59% discount.
Price
$0.00
Fair Value
$3.70
Uncertainty
Extreme
1-Star Price
$4.56
5-Star Price
$2.46
Economic Moat
Xml
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RSHN is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$2.57 Mil
Volume/Avg
15.1 Mil / 39.1 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

RushNet Inc through its subsidiary heliosDX, a National Clinical Reference Laboratory offers High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. The firm provides physicians individualized customer service, as well as fast and accurate reporting of results. The company invests in its infrastructure with the most efficient scientific proven instruments, and latest software for patient and physician satisfaction. It allows heliosDX to provide physicians fast and accurate reporting meeting. The firm excels in patient and client care through physician designed panels that aid in testing compliance and reporting education.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Total Number of Employees

Valuation

Metric
RSHN
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
RSHN
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
RSHN
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncFfct$216.6 Bil
DHR
Danaher CorpVfbmxz$186.9 Bil
IDXX
IDEXX Laboratories IncVcdykg$47.4 Bil
IQV
IQVIA Holdings IncChmcxkf$44.9 Bil
A
Agilent Technologies IncTbsj$38.7 Bil
ICLR
Icon PLCDrdfns$25.9 Bil
MTD
Mettler-Toledo International IncTdcrhy$25.6 Bil
ILMN
Illumina IncCrrqszn$21.5 Bil
WAT
Waters CorpPjrs$19.5 Bil
LH
Laboratory Corp of America HoldingsHzwbhb$18.3 Bil

Sponsor Center